Read More Pharma Industry News AstraZeneca’s Tagrisso secures FDA breakthrough therapy designation for first-line treatment of NSCLC AstraZeneca has achieved a significant milestone with its lung cancer drug, Tagrisso (osimertinib), which has recently been granted… bypharmanewsdailyOctober 15, 2017
